Diekema.ppt [Compatibility Mode] - Institute of Medicine

More documents

Recommendations

Info

ACIP Recommendations for Pneumococcal Conjugate Vaccine (PCV13) • For routine immunization <strong>of</strong> infants, PCV13 is recommended as a 4-dose series at ages 2, 4, 6, and 12--15 months •2010 recommendation for PCV13 superseded 2000 ACIP recommendation for PCV7 •2010-11 first season with PCV13 in widespread use MMWR. December 10, 2010 / 59(RR11);1-18
Febrile Seizures Signal in the Vaccine Safety Datalink (VSD) Harvard Pilgrim Health Care <strong>Institute</strong>, Southern California Kaiser Permanente, Centers for Disease Control and Prevention • Presented preliminary findings at February and June 2011 ACIP meetings • Methods and results published in February, 2012 •Tse et al. Vaccine 2012; 30:2024-2031 11
Page 1 and 2: Febrile Seizures Associated with Tr
Page 3 and 4: Febrile Seizure Signal Detection En
Page 5 and 6: ACIP General Recommendations Workin
Page 7 and 8: Febrile Seizures Background • Sei
Page 9: ACIP Recommendations for Influenza
Page 14 and 15: Lee, ACIP June 2011
Page 16 and 17: Lee, ACIP FEB 2011 16
Page 20 and 21: Joint Signal Evaluation for TIV and
Page 26 and 27: Updated VSD Analysis, August, 2011
Page 28 and 29: VSD Analysis - Comments • Compare
Page 30 and 31: Burden of Influenza Among Children
Page 33 and 34: Febrile Seizures After Influenza In
Page 35 and 36: 13-valent Pneumococcal Conjugate Va
Page 37 and 38: October 2011 ACIP Meeting General R
Page 39 and 40: October 2011 ACIP Meeting General R
Page 41 and 42: www.cdc.gov/vaccines/pubs/vis/
Page 43 and 44: Proposed Framework for Determining

Diekema.ppt [Compatibility Mode] - Institute of Medicine

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?